NASDAQ: MRKR
Marker Therapeutics Inc Stock Ownership - Who owns Marker Therapeutics?

Insider buying vs selling

Have Marker Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Steve ElmsDirector2024-12-2311,085$3.20
$35.47kBuy
New Enterprise Associates 16 LP10% Owner2024-12-23554,250$3.20
$1.77MBuy

1 of 1

MRKR insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MRKR insiders and whales buy or sell their stock.

MRKR Shareholders

What type of owners hold Marker Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Scott D. Sandell94.69%10,714,285$17.14MInsider
Peter W. Sonsini94.69%10,714,285$17.14MInsider
Ali Behbahani94.69%10,714,285$17.14MInsider
Carmen Chang94.69%10,714,285$17.14MInsider
Anthony A. Florence Jr.94.69%10,714,285$17.14MInsider
Mohamad Makhzoumi94.69%10,714,285$17.14MInsider
Joshua Makower94.69%10,714,285$17.14MInsider
Paul Edward Walker94.69%10,714,285$17.14MInsider
Forest Baskett94.69%10,714,285$17.14MInsider
John Robert Wilson69.04%7,812,008$12.50MInsider

1 of 3

MRKR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MRKR2.89%97.11%Net Buying
ASBP2.90%14.55%Net BuyingNet Buying
CING1.74%98.26%Net Selling
CGTX18.76%41.06%Net SellingNet Selling
CARM13.34%73.98%

Marker Therapeutics Stock Ownership FAQ

Who owns Marker Therapeutics?

Marker Therapeutics (NASDAQ: MRKR) is owned by 36.21% institutional shareholders, 1,217.46% Marker Therapeutics insiders, and 0.00% retail investors. Scott D. Sandell is the largest individual Marker Therapeutics shareholder, owning 10.71M shares representing 94.69% of the company. Scott D. Sandell's Marker Therapeutics shares are currently valued at $17.14M.

If you're new to stock investing, here's how to buy Marker Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.